{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+Draw+and+Baseline+Questionnaire", "query": { "intervention": "Blood Draw and Baseline Questionnaire" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 201, "total_pages": 21, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+Draw+and+Baseline+Questionnaire&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-13T21:52:18.237Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01096381", "title": "Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Cardiovascular Complications", "Colorectal Cancer", "Fallopian Tube Cancer", "Head and Neck Cancer", "Lung Cancer", "Ovarian Cancer", "Peritoneal Cavity Cancer", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Vanderbilt-Ingram Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2010-03", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2012-02-27", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 2, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01096381" }, { "nct_id": "NCT02253238", "title": "Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Head and Neck Cancer" ], "interventions": [ { "name": "Quality of Life Survey", "type": "BEHAVIORAL" }, { "name": "Health Management Surveys", "type": "BEHAVIORAL" }, { "name": "Monitoring Devices", "type": "OTHER" }, { "name": "Symptoms Surveys", "type": "BEHAVIORAL" }, { "name": "Device Usability Survey", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 427, "start_date": "2014-01-07", "completion_date": "2027-04-30", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02253238" }, { "nct_id": "NCT05386719", "title": "Cardiometabolic Screening Program", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Early-stage Breast Cancer" ], "interventions": [ { "name": "Prescreening", "type": "OTHER" }, { "name": "Screening and Enrollment", "type": "OTHER" }, { "name": "Baseline", "type": "BEHAVIORAL" }, { "name": "Interpret BMI", "type": "BEHAVIORAL" }, { "name": "Interpret HbA1c", "type": "OTHER" }, { "name": "Interpret lipid panel and assess other risk factors", "type": "OTHER" }, { "name": "Assess 10 year risk of cardiovascular event", "type": "BEHAVIORAL" }, { "name": "Recommendations", "type": "BEHAVIORAL" }, { "name": "Follow-Up", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 450, "start_date": "2022-06-03", "completion_date": "2027-08-01", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05386719" }, { "nct_id": "NCT06122896", "title": "Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Pancreatic Cancer", "Pancreatic Ductal Adenocarcinoma", "PDAC", "PDAC - Pancreatic Ductal Adenocarcinoma", "Pancreatic Neoplasm" ], "interventions": [ { "name": "Screening Blood Tests", "type": "OTHER" }, { "name": "Endoscopic Ultrasound", "type": "DIAGNOSTIC_TEST" }, { "name": "Magnetic Resonance Imaging", "type": "COMBINATION_PRODUCT" }, { "name": "Magnetic Resonance Cholangiopancreatography", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST", "COMBINATION_PRODUCT" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5000, "start_date": "2023-11-21", "completion_date": "2041-10-31", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06122896" }, { "nct_id": "NCT06932237", "title": "Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neuro-PASC", "Long COVID" ], "interventions": [], "intervention_types": [], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 200, "start_date": "2025-02-20", "completion_date": "2028-03-31", "has_results": false, "last_update_posted_date": "2026-03-31", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 2, "location_summary": "Portland, Oregon • Mountain Home, Tennessee", "locations": [ { "city": "Portland", "state": "Oregon" }, { "city": "Mountain Home", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06932237" }, { "nct_id": "NCT04166409", "title": "A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Low Grade Astrocytoma", "Low Grade Glioma", "Metastatic Low Grade Astrocytoma", "Metastatic Low Grade Glioma", "WHO Grade 1 Glioma", "WHO Grade 2 Glioma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Selumetinib Sulfate", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "2 Years to 21 Years" }, "enrollment_count": 170, "start_date": "2020-01-31", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 124, "location_summary": "Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 101 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04166409" }, { "nct_id": "NCT07579182", "title": "Hormones, Outcomes, and Pain Pathways in Exercise Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Pain", "Mastalgia", "Back Pain", "Back Pain, Low", "Neck Pain", "Chest Pain", "Activity, Motor", "Healthy Aging", "Weight, Body", "Inflammation", "Gonadal Steroid Hormones", "Neuronal Plasticity", "Neuromuscular Manifestations" ], "interventions": [ { "name": "Interventional Sports bra", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Houston", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "18 Years to 60 Years · Female only" }, "enrollment_count": 140, "start_date": "2026-05-17", "completion_date": "2029-09", "has_results": false, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07579182" }, { "nct_id": "NCT00002540", "title": "Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prostate Carcinoma" ], "interventions": [ { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Medical Examination Assessment", "type": "PROCEDURE" }, { "name": "Screening Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "74 Years", "sex": "MALE", "summary": "55 Years to 74 Years · Male only" }, "enrollment_count": 76685, "start_date": "1993-11-16", "completion_date": "2027-06-30", "has_results": true, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002540" }, { "nct_id": "NCT00573027", "title": "Heart Disease of the Small Arteries in Women and Men", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Disease" ], "interventions": [ { "name": "noninvasive tests", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 634, "start_date": "2005-11", "completion_date": "2040-01", "has_results": false, "last_update_posted_date": "2023-09-01", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00573027" }, { "nct_id": "NCT05705492", "title": "Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Malignant Solid Neoplasm", "Advanced Biliary Tract Carcinoma", "Advanced Esophageal Carcinoma", "Metastatic Esophageal Carcinoma", "Locally Advanced Colorectal Carcinoma", "Locally Advanced Esophageal Carcinoma", "Locally Advanced Gastric Carcinoma", "Metastatic Colorectal Carcinoma (mCRC)", "Advanced Lung Carcinoma", "Locally Advanced Hepatocellular Carcinoma" ], "interventions": [ { "name": "Olanzapine", "type": "DRUG" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2024-07-17", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-09-13T21:52:18.237Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT05705492" } ] }